| Primary |
| Product Used For Unknown Indication |
28.4% |
| Atrial Fibrillation |
23.7% |
| Arrhythmia |
10.5% |
| Drug Use For Unknown Indication |
7.3% |
| Hypertension |
4.7% |
| Multiple Drug Overdose Intentional |
2.8% |
| Heart Rate Irregular |
2.4% |
| Arrhythmia Supraventricular |
2.1% |
| Atrial Flutter |
2.1% |
| Supraventricular Tachycardia |
2.1% |
| Tachycardia |
2.1% |
| Blood Pressure |
1.9% |
| Drug Abuse |
1.6% |
| Extrasystoles |
1.4% |
| Diabetes Mellitus |
1.2% |
| Hypothyroidism |
1.2% |
| Palpitations |
1.2% |
| Anticoagulant Therapy |
1.0% |
| Blood Cholesterol |
1.0% |
| Cardiac Disorder |
1.0% |
|
| Product Quality Issue |
18.5% |
| Syncope |
9.9% |
| Vomiting |
9.3% |
| Overdose |
5.6% |
| Hypotension |
4.9% |
| Nausea |
4.3% |
| Sinus Bradycardia |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Vertigo |
4.3% |
| Brugada Syndrome |
3.7% |
| Drug Ineffective |
3.7% |
| Palpitations |
3.7% |
| Salivary Hypersecretion |
3.7% |
| Death |
3.1% |
| Electrocardiogram Qrs Complex Prolonged |
3.1% |
| Vision Blurred |
3.1% |
| Visual Impairment |
3.1% |
| Atrial Fibrillation |
2.5% |
| Completed Suicide |
2.5% |
| Hepatitis Acute |
2.5% |
|
| Secondary |
| Atrial Fibrillation |
25.2% |
| Drug Use For Unknown Indication |
16.5% |
| Product Used For Unknown Indication |
13.1% |
| Suicide Attempt |
9.1% |
| Arrhythmia |
8.2% |
| Hypertension |
5.3% |
| Multiple Drug Overdose Intentional |
5.3% |
| Coronary Artery Disease |
2.2% |
| Anxiety |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
| Ulcer |
1.8% |
| Heart Rate Irregular |
1.3% |
| Thrombosis |
1.1% |
| Atrial Flutter |
0.9% |
| Blood Cholesterol |
0.9% |
| Depression |
0.9% |
| Dyspnoea |
0.9% |
| Extrasystoles |
0.9% |
| Headache |
0.9% |
|
| Completed Suicide |
13.3% |
| Syncope |
11.2% |
| Suicide Attempt |
8.2% |
| Sopor |
6.1% |
| Hypotension |
5.1% |
| Nausea |
5.1% |
| Cardiac Arrest |
4.1% |
| Drug Interaction |
4.1% |
| Heart Rate Increased |
4.1% |
| Nodal Arrhythmia |
4.1% |
| Pemphigoid |
4.1% |
| Poisoning |
4.1% |
| Pulse Absent |
4.1% |
| Toxicity To Various Agents |
4.1% |
| Atrial Tachycardia |
3.1% |
| Brugada Syndrome |
3.1% |
| Dizziness |
3.1% |
| Fall |
3.1% |
| Palpitations |
3.1% |
| Ventricular Fibrillation |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.6% |
| Drug Use For Unknown Indication |
19.5% |
| Atrial Fibrillation |
14.0% |
| Hypertension |
10.6% |
| Rheumatoid Arthritis |
3.6% |
| Diabetes Mellitus |
3.3% |
| Prophylaxis |
3.3% |
| Arrhythmia |
2.8% |
| Cardiac Disorder |
2.3% |
| Blood Cholesterol Increased |
2.2% |
| Non-small Cell Lung Cancer |
2.0% |
| Depression |
1.9% |
| Hypothyroidism |
1.9% |
| Osteoporosis |
1.6% |
| Pain |
1.5% |
| Tachycardia |
1.4% |
| Breast Cancer |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Asthma |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
|
| Weight Decreased |
20.0% |
| Vomiting |
10.0% |
| Weight Increased |
6.5% |
| Atrial Fibrillation |
5.3% |
| Nausea |
5.3% |
| Oedema Peripheral |
5.3% |
| Arrhythmia |
4.1% |
| Cerebrovascular Accident |
4.1% |
| Sepsis |
4.1% |
| Drug Ineffective |
3.5% |
| Headache |
3.5% |
| Myelodysplastic Syndrome |
3.5% |
| Respiratory Failure |
3.5% |
| Upper Gastrointestinal Haemorrhage |
3.5% |
| Anaemia |
2.9% |
| Cardiac Failure |
2.9% |
| Death |
2.9% |
| Dyspnoea |
2.9% |
| Fall |
2.9% |
| Flushing |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
71.4% |
| Anxiety |
7.1% |
| Breast Cancer |
7.1% |
| Depression |
7.1% |
| Supraventricular Tachycardia |
7.1% |
|
| Aortic Bruit |
20.0% |
| Drug Interaction |
20.0% |
| Nausea |
20.0% |
| Palpitations |
20.0% |
| Syncope |
20.0% |
|
